Decitabine improves overall survival in myelodysplastic syndromes-RAEB patients aged ≥60 years and has lower toxicities: Comparison with low-dose chemotherapy
Autor: | Ye, Li, Ren, Yanling, Zhou, Xinping, Mei, Chen, Xu, Weilai, Ma, Liya, Luo, Yingwan, Hu, Chao, Ye, Xingnong, Wei, Juying, Lou, Yinjun, Jin, Jie, Tong, Hongyan |
---|---|
Zdroj: | In Blood Cells, Molecules and Diseases July 2019 77:88-94 |
Databáze: | ScienceDirect |
Externí odkaz: |